Scotia Capital’s NEVRO CORP. NVRO Stock Holding History

Scotia Capital’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,460	Closed	-$231K	–	749
2017 Q1	$231K	Buy	+2,460	New	+$223K	﹤0.01%	648

Other funds holding NVRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Scotia Capital's NVRO Position: Q2 2017 in Review

Scotia Capital sold out of NEVRO CORP. (NVRO) in Q2 2017, closing a stake of 2,460 shares — an estimated $231K sold.

Scotia Capital first reported a position in NVRO in Q1 2017 and held it in 1 quarter. The position peaked at $231K in Q1 2017. 201 funds tracked by Wall St. Rank hold NVRO as of Q2 2017.

Scotia Capital reported no remaining NEVRO CORP. position as of Q2 2017 after selling out during the quarter.
Scotia Capital sold 2,460 NEVRO CORP. shares in Q2 2017, an estimated $231K.
Scotia Capital first reported a position in NEVRO CORP. in Q1 2017 and held it in 1 quarter.
Scotia Capital's NEVRO CORP. position peaked at $231K in Q1 2017.
201 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2017.

Based on Scotia Capital's 13F filing for Q2 2017, filed 15 Aug 2017.